Novel 5-flucytosine-resistant clade of Candida dubliniensis from Saudi Arabia and Egypt identified by Cd25 fingerprinting

被引:26
作者
Al Mosaid, A
Sullivan, DJ
Polacheck, I
Shaheen, FA
Soliman, O
Al Hedaithy, S
Al Thawad, S
Kabadaya, M
Coleman, DC
机构
[1] Univ Dublin Trinity Coll, Dublin Dent Sch & Hosp, Microbiol Res Div, Dublin 2, Ireland
[2] Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Clin Microbiol & Infect Dis, Jerusalem, Israel
[3] King Fahad Hosp, Jeddah Kidney Ctr, Jeddah, Saudi Arabia
[4] Natl Canc Inst, Cairo, Egypt
[5] King Saud Univ, King Khalid Univ Hosp, Dept Pathol, Med Mycol Unit, Riyadh 11472, Saudi Arabia
[6] King Faisal Specialist Hosp & Res Ctr, Dept Pathol & Lab Med, Microbiol Lab, Riyadh 11211, Saudi Arabia
关键词
D O I
10.1128/JCM.43.8.4026-4036.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
DNA fingerprinting of Candida dubliniensis isolates using the species-specific probe Cd25 previously showed that this species consists of two distinct groups, termed Cd25 group I and Cd25 group II. The present study investigated the population structure of 30 C. dubliniensis oral isolates from Saudi Arabia and Egypt using Cd25 fingerprinting and rRNA gene internal transcribed spacer region-based genotyping. Cd25 fingerprinting analysis of these isolates revealed two distinct populations, the first of which consisted of 10 closely related genotype 1 isolates (average similarity coefficient [S(AB)] value, 0.86). The second population of 20 isolates was much more heterogeneous (average S(AB) value, 0.35) and consisted of two distinct subpopulations, one of which consisted of genotype 3 isolates (n = 13) and the other of genotype 4 isolates (n = 7). A mixed dendrogram generated from the fingerprint data from the 30 Saudi Arabian and Egyptian isolates, 5 Israeli isolates, and 51 previously characterized international isolates (32 of Cd25 group I and 19 of Cd25 group II) revealed the presence of three distinct main clades. The first corresponded to the previously described Cd25 group I and contained all the Saudi Arabian, Egyptian, and Israeli genotype I isolates mixed with international isolates. The second clade corresponded to the previously described Cd25 group II and contained three Israeli isolates, one genotype 2 isolate, one genotype 3 isolate, and a genotype 4 variant isolate, which were mixed with international isolates. The third clade has not been described before and consisted solely of the 20 Saudi Arabian and Egyptian genotype 3 and 4 isolates identified in this study and a previously described genotype 4 Israeli isolate. All 20 Cd25 group III isolates exhibited high-level resistance to 5-flucytosine (MIC <= 128 mu g/ml), whereas all Cd25 group I and Cd25 group II isolates tested (10 Saudi Arabian and Egyptian, 16 Israeli, and 24 international) were susceptible to 5-flucytosine (MIC <= 0.125 mu g/ml). The results of this study show for the first time the presence of a novel 5-fiucytosine-resistant clade of C. dubliniensis (Cd25 group III) that is predominant among isolates from Saudi Arabia and Egypt and absent from a previously characterized international collection of 98 isolates from 15 countries.
引用
收藏
页码:4026 / 4036
页数:11
相关论文
共 52 条
[1]   Isolation and molecular identification of Candida dubliniensis from non-human immunodeficiency virus-infected patients in Kuwait [J].
Ahmad, S ;
Khan, Z ;
Mokaddas, E ;
Khan, ZU .
JOURNAL OF MEDICAL MICROBIOLOGY, 2004, 53 (07) :633-637
[2]   Differentiation of Candida dubliniensis from Candida albicans on Pal's agar [J].
Al Mosaid, A ;
Sullivan, DJ ;
Coleman, DC .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (10) :4787-4789
[3]   Differentiation of Candida dubliniensis from Candida albicans on Staib agar and caffeic acid-ferric citrate agar [J].
Al Mosaid, A ;
Sullivan, D ;
Salkin, IF ;
Shanley, D ;
Coleman, DC .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (01) :323-327
[4]  
[Anonymous], 1990, PCR PROTOCOLS, DOI DOI 10.1016/B978-0-12-372180-8.50042-1
[5]  
[Anonymous], 1997, PERFECT BEAT
[6]  
[Anonymous], 1983, COLD SPRING HARBOR L
[7]   High prevalence of non-albicans yeasts and detection of anti-fungal resistance in the oral flora of patients with advanced cancer [J].
Bagg, J ;
Sweeney, MP ;
Lewis, MAO ;
Coleman, D ;
Al Mosaid, A ;
Baxter, W ;
McEndrick, S ;
McHugh, S .
PALLIATIVE MEDICINE, 2003, 17 (06) :477-481
[8]   Racial distribution of Candida dubliniensis colonization among South Africans [J].
Blignaut, E ;
Pujol, C ;
Joly, S ;
Soll, DR .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (05) :1838-1842
[9]   Ca3 fingerprinting of Candida albicans isolates from human immunodeficiency virus-positive and healthy individuals reveals a new clade in South Africa [J].
Blignaut, E ;
Pujol, C ;
Lockhart, S ;
Joly, S ;
Soll, DR .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (03) :826-836
[10]   Candida dubliniensis Fungemia:: the first four cases in North America [J].
Brandt, ME ;
Harrison, LH ;
Pass, M ;
Sofair, AN ;
Huie, S ;
Li, RK ;
Morrison, CJ ;
Warnock, DW ;
Hajjeh, RA .
EMERGING INFECTIOUS DISEASES, 2000, 6 (01) :46-49